Camilla Sylvest

Director/Board Member at ARGENX SE

Net worth: 3 M $ as of 30/06/2026

54 year

73 connections

Health Technology

Consumer Services

Consumer Non-Durables

Profile

Camilla Sylvest is currently an Independent Non-Executive Director at argenx SE since 2022, a Director at Zealand Pharma A starting in 2026, and an Independent Director at Getinge AB starting in 2026.
Former roles include Vice Chairman at World Diabetes Foundation, Independent Director at Danish Crown A, Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH, and EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A from 2017 to 2025.
Education includes a graduate degree from the University of Southern Denmark in 1998 and an MBA from Scandinavian International Management Institute in 2003.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ARGENX SE 0%	30/06/2026	3,049 ( 0% )	3 M $	30/06/2026

Camilla Sylvest active positions

Companies	Position	Start
ARGENX SE	Director/Board Member	08/09/2022
GETINGE AB	Director/Board Member	21/04/2026
ZEALAND PHARMA A/S	Director/Board Member	26/05/2026

All active positions of Camilla Sylvest

Former positions of Camilla Sylvest

Companies	Position	End
NOVO NORDISK A/S	Corporate Officer/Principal	03/04/2025
World Diabetes Foundation World Diabetes Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Director/Board Member	-
Danish Crown A/S Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Engages in processing and sale of chilled & frozen meat products, pork, beef, poultry and lamb	Director/Board Member	-
Novo Nordisk Pharma GmbH Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Corporate Officer/Principal	-

See the detail of Camilla Sylvest's experience

Training of Camilla Sylvest

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Camilla Sylvest's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Novo Nordisk Pharma GmbH Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
Getinge AB Getinge AB Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and disinfectants	Health Technology
Zealand Pharma A/S Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines	Health Technology
University of Southern Denmark University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Scandinavian International Management Institute Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Danish Crown A/S Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Engages in processing and sale of chilled & frozen meat products, pork, beef, poultry and lamb	Consumer Non-Durables
argenx SE argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases	Health Technology
World Diabetes Foundation World Diabetes Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Miscellaneous